44 /100
MEDIUM RISK
Score updated May 30, 2026

ANTX — AN2 Therapeutics, Inc. Dilution Risk Tracker

Track ANTX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ANTX — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
100
💰 Cash Runway
0
📊 Float Risk
40
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

Watch
Minor dilution signals detected
19%
💰 Capital Raise 38%
• Active shelf registration ($300M, 192% of market cap)
• Active ATM program with $80M remaining capacity
🔔 Track ANTX — Get forecast alerts →

💹 Market Data

Market Cap$155.95M
Shares Outstanding36.02M
Float17.02M
Cash$85.29M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 6.9% shares (2025Q4 vs prior)
37 institutional holders · 9.05M shares
#1 Almitas Capital LLC 1.48M shares
#2 VANGUARD GROUP INC 1.08M shares
#3 BANK OF AMERICA CORP /DE/ 770.6K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest836.4K
Days to Cover3.5
% of Float4.9%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jun 30, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2022
424B3 ATM Apr 20, 2026
424B5 ATM Apr 20, 2026
EFFECT EFFECT Apr 20, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track ANTX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ANTX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for ANTX
📊 ANTX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ANTX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.